The answer to the following question was supplied by LCGC's "GC Connections" columnist John Hinshaw.
The answer to the following question was supplied by LCGC's “GC Connections” columnist John Hinshaw.
Q: What are the main causes of GC column degradation or decline in performance?
John Hinshaw: There are four main causes of GC column degradation and performance decline.
First, columns are degraded by the build-up of nonvolatile sample residues that interact with target analytes to cause peak tailing, catalytic decomposition, and ultimately loss of separation. Proper sample preparation, the use of a retention gap, and inlet liner maintenance will help alleviate this problem. Trimming the beginning of a contaminated column can recover some performance. Headspace sampling, when possible, completely eliminates this problem.
Second, chemically active substances in the sample such as derivatization reagents and their by-products can degrade the stationary phase and will lead to significant performance losses. Careful choice of derivatization reagents and avoidance of excessive amounts will help reduce this effect. Some stationary phases are less susceptible to these effects.
Third, the presence of oxygen in the carrier gas from leaks or poor quality gas cylinders will degrade some stationary phases, such as Carbowax and bonded Carbowax types. Attention to carrier gas quality, the use of fresh oxygen filters, and leak-free connections will ensure a longer lifetime for these columns.
Fourth, excessively high operating or conditioning temperatures will age a column prematurely. Never exceed the maximum operating temperature when performing separations, and never exceed the recommended conditioning temperature and duration.
Determining Neurotransmitters in Spinal Cords with UHPLC
February 18th 2025Researchers at Jilin University (Changchun, China) developed a highly sensitive, rapid, and accurate method for analyzing neurotransmitters (NTs) in rat spinal cord tissue. Ultra-high performance liquid chromatography-triple quadrupole tandem mass spectrometry (UHPLC-QqQ-MS/MS) in conjunction with ultra-ionic liquid dispersive liquid-liquid microextraction (UA-MIL-DLLME) were used to extract NTs for analysis.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Revolutionizing LC-MS with Next-Gen Separation for Cyclic Peptide Analysis
February 17th 2025Cyclic peptides, known for their stability and high specificity, are promising therapeutic agents in the fight against cancer, infections, and autoimmune diseases. However, developing effective cyclic peptides presents numerous challenges, including poor pharmacokinetics, efficacy, and toxicity. Traditional methods like liquid chromatography tandem-mass spectrometry (LC-MS/MS) often struggle with resolving isomeric linear peptide metabolites, posing significant risks in safety, efficacy, and regulatory approval. In this paper, Komal Kedia, PhD, will share how she leveraged MOBIE’s high-resolution ion mobility-mass spectrometry (IM-MS) system to achieve a 72% reduction in run times, 200% greater resolving power, and enhanced accuracy in identifying “soft spots” prone to enzymatic degradation.